Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 42,258 shares at $33.25 ($1.4M) on 2020-10-08, disclosed to the SEC on 2020-10-13.
Open-market sale of $1.4M BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.25 | 7,774 | $258K | 18.3% |
| 2 | $33.25 | 7,774 | $258K | 18.3% |
| 3 | $33.25 | 1,027 | $34K | 2.4% |
| 4 | $33.68 | 8,502 | $286K | 20.2% |
| 5 | $33.68 | 1,122 | $38K | 2.7% |
| 6 | $33.68 | 8,502 |
| $286K |
| 20.2% |
| 7 | $33.67 | 443 | $15K | 1.1% |
| 8 | $33.67 | 3,357 | $113K | 8.0% |
| 9 | $33.67 | 3,357 | $113K | 8.0% |
| 10 | $33.11 | 47 | $2K | 0.1% |
| 11 | $33.11 | 353 | $12K | 0.8% |
| Total | $33.50 avg | 42,258 | $1.4M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |